fenoxaprop ethyl has been researched along with vorinostat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adomat, H; Bacha, J; Brown, D; Collins, C; Daugaard, M; Ghaidi, F; Joshi, J; Kung, SHY; Lallous, N; Langlands, J; Le Bihan, S; Lizardo, MM; Oo, HZ; Ramos, L; Rezakhanlou, AM; Shen, W; Shyp, T; Sorensen, PH; Truong, S; Zhai, B | 1 |
1 other study(ies) available for fenoxaprop ethyl and vorinostat
| Article | Year |
|---|---|
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.
Topics: Animals; Histone Deacetylase Inhibitors; Humans; Poly(ADP-ribose) Polymerase Inhibitors; Puma; Sarcoma, Ewing; Vorinostat | 2023 |